We also show that BAZ2‐ICR is not able to recapitulate the effects observed with BAZ2A genetic ablation; this was also recently demonstrated by a different research group reporting that BAZ2‐ICR does not affect the proliferation of heterogeneous PCa cell population while being effective on PCa cancer stem cells (Peña‐Hernández et al., 2021). The gene discussed is ZNF215; the disease is posterior cortical atrophy.